Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Structure and function of the Epstein-Barr virus BZLF1 protein.

Packham G, Economou A, Rooney CM, Rowe DT, Farrell PJ.

J Virol. 1990 May;64(5):2110-6.

2.

Epstein-Barr virus BZLF1 transactivator is a negative regulator of Jun.

Sato H, Takeshita H, Furukawa M, Seiki M.

J Virol. 1992 Aug;66(8):4732-6.

3.
4.

Strain variation in Epstein-Barr virus immediate early genes.

Packham G, Brimmell M, Cook D, Sinclair AJ, Farrell PJ.

Virology. 1993 Feb;192(2):541-50.

PMID:
8093650
5.

Pathways of activation of the Epstein-Barr virus productive cycle.

Sinclair AJ, Brimmell M, Shanahan F, Farrell PJ.

J Virol. 1991 May;65(5):2237-44.

6.
7.
8.

Activation of oriLyt, the lytic origin of DNA replication of Epstein-Barr virus, by BZLF1.

Schepers A, Pich D, Hammerschmidt W.

Virology. 1996 Jun 15;220(2):367-76.

9.

Direct BRLF1 binding is required for cooperative BZLF1/BRLF1 activation of the Epstein-Barr virus early promoter, BMRF1.

Quinlivan EB, Holley-Guthrie EA, Norris M, Gutsch D, Bachenheimer SL, Kenney SC.

Nucleic Acids Res. 1993 Jul 11;21(14):1999-2007.

10.

Epstein-Barr virus polymerase processivity factor enhances BALF2 promoter transcription as a coactivator for the BZLF1 immediate-early protein.

Nakayama S, Murata T, Murayama K, Yasui Y, Sato Y, Kudoh A, Iwahori S, Isomura H, Kanda T, Tsurumi T.

J Biol Chem. 2009 Aug 7;284(32):21557-68. doi: 10.1074/jbc.M109.015685. Epub 2009 Jun 2.

11.

ZEBRA and a Fos-GCN4 chimeric protein differ in their DNA-binding specificities for sites in the Epstein-Barr virus BZLF1 promoter.

Taylor N, Flemington E, Kolman JL, Baumann RP, Speck SH, Miller G.

J Virol. 1991 Aug;65(8):4033-41.

12.

The chemopreventive compound curcumin is an efficient inhibitor of Epstein-Barr virus BZLF1 transcription in Raji DR-LUC cells.

Hergenhahn M, Soto U, Weninger A, Polack A, Hsu CH, Cheng AL, Rösl F.

Mol Carcinog. 2002 Mar;33(3):137-45.

PMID:
11870879
13.

Functional and physical interactions between the Epstein-Barr virus (EBV) proteins BZLF1 and BMRF1: Effects on EBV transcription and lytic replication.

Zhang Q, Hong Y, Dorsky D, Holley-Guthrie E, Zalani S, Elshiekh NA, Kiehl A, Le T, Kenney S.

J Virol. 1996 Aug;70(8):5131-42.

14.
15.
16.

Comparing transcriptional activation and autostimulation by ZEBRA and ZEBRA/c-Fos chimeras.

Kolman JL, Taylor N, Gradoville L, Countryman J, Miller G.

J Virol. 1996 Mar;70(3):1493-504.

17.
18.
19.
20.

RAZ, an Epstein-Barr virus transdominant repressor that modulates the viral reactivation mechanism.

Furnari FB, Zacny V, Quinlivan EB, Kenney S, Pagano JS.

J Virol. 1994 Mar;68(3):1827-36.

Supplemental Content

Support Center